In vitro studies of 3-hydroxy-4-pyridinones and their glycosylated derivatives as potential agents for Alzheimer's disease.

Glycosides of 3-hydroxy-4-pyridinones were synthesized and characterized by mass spectrometry, elemental analysis, (1)H and (13)C NMR spectroscopy, and in one case by X-ray crystallography. The Cu(2+) complex of a novel 3-hydroxy-4-pyridinone was synthesized and characterized by IR and X-ray crystallography, showing the ability of these compounds to chelate potentially toxic metal ions. An MTT cytotoxicity assay of a selected glycosylated compound showed a relatively low toxicity of IC(50) = 570 +/- 90 microM in a human breast cancer cell line. The pyridinone glycosides could be cleaved by a broad specificity beta-glycosidase, Agrobacterium sp.beta-glucosidase, and for one compound k(cat) and K(m) were determined to be 19.8 s(-1) and 1.52 mM, respectively. Trolox Equivalent Antioxidant Capacity (TEAC) values were determined for the free pyridinones, indicating the good antioxidant properties of these compounds. Metal-Abeta(1-40) aggregates with zinc and copper were resolubilized by the non-glycosylated pyridinone ligands.

Glycosylated tetrahydrosalens as multifunctional molecules for Alzheimer's therapy.

The tetrahydrosalens N,N'-bis(2-hydroxybenzyl)-ethane-1,2-diamine ((2)(1)), N,N'-bis(2-hydroxybenzyl)-(-)-1,2-cyclohexane-(1R,2R)-diamine ((2)(2)), N,N'-bis(2-hydroxybenzyl)-N,N'-dimethyl-ethane-1,2-diamine ((2)(3)), N,N'-bis(2-hydroxybenzyl)-N,N'-dibenzyl-ethane-1,2-diamine ((2)(4)), and N,N'-bis(2-(4-tert-butyl)hydroxybenzyl)-ethane-1,2-diamine ((2)(5)), as well as their prodrug glycosylated forms, (1-5), have been prepared and evaluated in vitro for their potential use as Alzheimer's disease (AD) therapeutics. Dysfunctional interactions of metal ions, especially those of Cu, Zn, and Fe, with the amyloid-beta (Abeta) peptide are hypothesised to play an important role in the aetiology of AD, and disruption of these aberrant metal-peptide interactions via chelation therapy holds considerable promise as a therapeutic strategy. Tetrahydrosalens such as (2)(1-5) have a significant affinity for metal ions, and thus should be able to compete with the Abeta peptide for Cu, Zn, and Fe in the brain. This activity was assayed in vitrovia a turbidity assay; (2)(1) and (2)(3) were found to attenuate Abeta(1-40) aggregation after exposure to Cu(2+) and Zn(2+). In addition, (2)(1-5) were determined to be potent antioxidants on the basis of an in vitro antioxidant assay. (1-5) were prepared as metal binding prodrugs; glycosylation is intended to prevent systemic metal binding, improve solubility, and enhance brain uptake. Enzymatic (beta-glucosidase) deprotection of the carbohydrate moieties was facile, with the exception of (4), demonstrating the general feasibility of this prodrug approach. Finally, a representative prodrug, (3), was determined to be non-toxic over a large concentration range in a cell viability assay.

Solid-state changes in ligand-to-metal charge-transfer spectra of (NH3)5Ru(III)(2,4-dihydroxybenzoate) and (NH3)5Ru(III)(xanthine) chromophores.

Five distorted-octahedral complexes containing (NH3)5Ru(III)L ions, where L = 2,4-dihydroxybenzoate or a xanthine, have been studied using a combination of X-ray crystallography, solution and polarized single-crystal electronic absorption spectroscopy, and first principles electronic structure computational techniques. Both yellow (2) and red (3) forms of the complex (NH3)5Ru(III)L, where L = 2,4-dihydroxybenzoate, as well as three xanthine complexes in which L = hypoxanthine-kappaN(7) (4), 7-methylhypoxanthine-kappaN(9) (5), and 1,3,9-trimethylxanthine-kappaN(7) (6) were examined. In the solid state, some of these complexes exhibit split low-energy ligand-to-metal charge-transfer (LMCT) bands. Traditional solid-state effects, such as ligand pi-pi overlap or hydrogen bonding that might lead to splitting of electronic absorption bands, were probed in an attempt to identify the origins of these unusual observations. For comparison, companion studies were carried out for spectroscopically normal reference complexes of the same ligands. Time-dependent density-functional theory (TD-DFT) calculations, employing modified B3LYP-type functionals with increased contributions of exact exchange, attribute the color change in the crystalline complexes 2 and 3 to pi(ligand) --> Ru[d(pi)] LMCT bands which, in the red form (3), arise from ligand donor pi-orbitals split by strongly overlapping phenyl moieties in centrosymmetric (NH3)5Ru(III)(2,4-dihydroxybenzoate) dimers. Complex 5 does not show split visible absorptions, whereas both the polarizations and energies of the split visible absorptions shown by 4 and 6 also suggest assignment as LMCT. No support is found for relating the split absorptions of 4 and 6 to the details of pi-pi xanthine overlap in the solid state; indeed, complex 4 enjoys considerably less pi-stacking overlap than does 5. We feel compelled to attribute the split absorptions in crystalline 4 and 6 to the emergence of a LMCT transition originating in the carbonyl lone pair, potentially deriving intensity from the significant intramolecular N-H...O hydrogen bonding present in both 4 and 6 (but not in 5). The electronic structure calculations suggest an O(n) --> Ru[d(sigma*)] LMCT transition; however, this novel assignment must be considered tentative.

Synthesis, characterization, and metal coordinating ability of multifunctional carbohydrate-containing compounds for Alzheimer's therapy.

Dysfunctional interactions of metal ions, especially Cu, Zn, and Fe, with the amyloid-beta (A beta) peptide are hypothesized to play an important role in the etiology of Alzheimer's disease (AD). In addition to direct effects on A beta aggregation, both Cu and Fe catalyze the generation of reactive oxygen species (ROS) in the brain further contributing to neurodegeneration. Disruption of these aberrant metal-peptide interactions via chelation therapy holds considerable promise as a therapeutic strategy to combat this presently incurable disease. To this end, we developed two multifunctional carbohydrate-containing compounds N,N'-bis[(5-beta-D-glucopyranosyloxy-2-hydroxy)benzyl]-N,N'-dimethyl-ethane-1,2-diamine (H2GL1) and N,N'-bis[(5-beta-D-glucopyranosyloxy-3-tert-butyl-2-hydroxy)benzyl]-N,N'-dimethyl-ethane-1,2-diamine (H2GL2) for brain-directed metal chelation and redistribution. Acidity constants were determined by potentiometry aided by UV-vis and 1H NMR measurements to identify the protonation sites of H2GL1,2. Intramolecular H bonding between the amine nitrogen atoms and the H atoms of the hydroxyl groups was determined to have an important stabilizing effect in solution for the H2GL1 and H2GL2 species. Both H2GL1 and H2GL2 were found to have significant antioxidant capacity on the basis of an in vitro antioxidant assay. The neutral metal complexes CuGL1, NiGL1, CuGL2, and NiGL2 were synthesized and fully characterized. A square-planar arrangement of the tetradentate ligand around CuGL2 and NiGL2 was determined by X-ray crystallography with the sugar moieties remaining pendant. The coordination properties of H2GL1,2 were also investigated by potentiometry, and as expected, both ligands displayed a higher affinity for Cu2+ over Zn2+ with H2GL1 displaying better coordinating ability at physiological pH. Both H2GL1 and H2GL2 were found to reduce Zn2+- and Cu2+- induced Abeta1-40 aggregation in vitro, further demonstrating the potential of these multifunctional agents as AD therapeutics.

A tris(pyrazolyl) eta6-arene ligand that selects Cu(I) over Cu(II).

1,3,5-Tris{2'-[(pyrazol-1-yl)methyl]phenyl}benzene, 4, and its complexes with Cu(I) and Ag(I) have been prepared and characterized. Both CuI4 and AgI4 triflate crystallize in the rhombohedral space group R3, with the cations and anions each exhibiting crystallographically imposed 3-fold (C3) symmetry. In both complexes, 4 behaves as a tris(pyrazolyl) eta6-arene ligand whose arms act as three-pronged tweezers to form chiral, propeller-like cations with pyramidal MN(pyrazole)3 coordination geometries. Centers of symmetry in the space group ensure that the crystals are racemates, with equal numbers of P,P,P and M,M,M enantiomers. In broad outline, each cation is shaped like a three-legged stool, with the metal ion centered at the top and pointed downward from a triangular N(pyrazole) plane toward the center of gravity (Cg) of the central benzene ring (a metal-endo conformation), which constitutes the bottom shelf of the stool. The Cu(I)...Cg and Ag(I)...Cg distances, 3.195(2) and 3.165(2) A, respectively, support the existence of an eta6 bonding interaction with Ag(I) and, to a lesser extent, with Cu(I). NMR data for AgI4 suggest rapid interconversion of this cation in solution between P,P,P and M,M,M enantiomers. Our inability to prepare any Cu(II) complexes with 4 is consistent with cyclovoltammetric results, which suggest that the ligand is more easily oxidized than Cu(I).

Structural and spectroscopic features of mono- and binuclear nickel(II) complexes with tetradentate N(amine)2S(thiolate)2 ligation.

Three complexes containing Ni(II)N(amine)2S(thiolate)2 units have been prepared and characterized. Both (R,R)-N,N'-bis(1-carboxy-2-mercaptoethyl)-1,2-diaminoethane [(R,R)-1] and N,N'-bis(2-methyl-2-mercaptoprop-1-yl)-1,3-diamino-2,2-dimethylpropane (4) act as tetradentate S-N-N-S ligands to form complexes Ni((R,R)-1) and Ni4 with nearly planar cis-NiN2S2 units. The N-Ni-N and S-Ni-S angles differ significantly in the two complexes yet are very nearly supplementary. The 1,3-disubstituted cyclohexane species rac-N,N'-bis(2-mercapto-2-methylprop-1-yl)-1,3-cyclohexanediamine (6) behaves as a bis(bidentate-N,S) ligand to form an unexpectedly intense-blue dinickel complex (1S,3R,1'S,3'R)-7, which contains two trans-NiN2S2 units bridged by 1,3-disubstituted cyclohexane groups. The coordination geometry in (1S,3R,1'S,3'R)-7 is distorted 15 degrees toward tetrahedral, most likely as a result of steric crowding, suggested by several short contacts between the NiS2 units and both the cyclohexyl and gem-dimethyl groups of the N,S-chelate rings. The complexes exhibit rich UV-vis spectra, whose deconvoluted bands are now fully assigned, from low to high energy, as ligand field (LF), pi(S) --> Ni(II) ligand-to-metal charge transfer (LMCT), sigma(S) --> Ni(II) LMCT, sigma(N) --> Ni(II) LMCT, localized S, and S,N Rydberg transitions. The unusually intense LF absorptions shown by (1S,3R,1'S,3'R)-7 are thought to result from relaxation of the Laporte restriction arising from the 15 degrees tetrahedral twist.

Three structures containing (E)-1,2-bis(benzimidazol-2-yl)ethene groups.

Two of the title compounds, namely (E)-1,2-bis(1-methylbenzimidazol-2-yl)ethene, C18H16N4, (Ib), and (E)-1,2-bis(1-ethylbenzimidazol-2-yl)ethene, C20H20N4, (Ic), consist of centrosymmetric trans-bis(1-alkylbenzimidazol-2-yl)ethene molecules, while 3-ethyl-2-[(E)-2-(1-ethylbenzimidazol-2-yl)ethenyl]benzimidazol-1-ium perchlorate, C20H21N4+.ClO4-, (II), contains the monoprotonated analogue of compound (Ic). In the three structures, the benzimidazole and benzimidazolium moieties are essentially planar; the geometric parameters for the ethene linkages and their bonds to the aromatic groups are consistent with double and single bonds, respectively, implying little, if any, conjugation of the central C=C bonds with the nitrogen-containing rings. The C-N bond lengths in the N=C-N part of the benzimidazole groups differ and are consistent with localized imine C=N and amine C-N linkages in (Ib) and (Ic); in contrast, the corresponding distances in the benzimidazolium cation are equal in (II), consistent with electron delocalization resulting from protonation of the amine N atom. Crystals of (Ib) and (Ic) contain columns of parallel molecules, which are linked by edge-over-edge C-H...pi overlap. The columns are linked to one another by C-H...pi interactions and, in the case of (Ib), C-H...N hydrogen bonds. Crystals of (II) contain layers of monocations linked by pi-pi interactions and separated by both perchlorate anions and the protruding ethyl groups; the cations and anions are linked by N-H...O hydrogen bonds.

A geometrically constraining bis(benzimidazole) ligand and its nearly tetrahedral complexes with Fe(II) and Mn(II).

2,2'-Bis[2-(1-propylbenzimidazol-2-yl)]biphenyl), 4, and its bis complexes with Fe(II) and Mn(II) have been prepared and characterized structurally and spectroscopically. Ligand 4 adopts an open, "trans" conformation in the solid state with the benzimidazole (BzIm) groups on opposite sides of the biphenyl unit. In its complexes with metal ions, a "cis" conformation is observed, and 4 behaves as a geometrically constraining bidentate ligand with four planar groups connected by three "hinges". Reaction of 4 with Fe(II) or Mn(II) yielded isomorphous crystals (space group Pnn2) of Fe(II)(4)2.(ClO4)2 and Mn(II)(4)2.(ClO4)2, in which the M(II)(4)2 cations exhibit distorted-tetrahedral coordination geometries (N-M-N angles, 109 +/- 11 degrees ) enforced by rigid, chiral nine-membered M(4) rings in the twist-boat-boat conformation. Individually, the cations show R,R or S,S stereochemistry, and the crystals are racemates. Mn(II)(4)2.(ClO4)2 exhibits a quasi-reversible Mn(II) --> Mn(III) oxidation at E(1/2) = 0.64 V; the corresponding Fe(II) --> Fe(III) oxidation occurs at E(1/2) = 1.76 V. The electrochemical stability of the Fe(III) oxidation state in this system suggests the possibility of isolating an unusual pseudotetrahedral Fe(III)N(BzIm)(4) species. Ultraviolet spectra of the iron and manganese complexes are dominated by absorptions of the ligand 4 blue-shifted by approximately 2000-3000 cm(-1). Ligand-field absorptions were observed for the Fe(II) complex; those for the Mn(II) complex were obscured by tailing ultraviolet absorptions. Electron paramagnetic resonance and magnetic susceptibility measurements are consistent with a high-spin Mn(II) complex, while for the Fe(II) complex, the falloff of the magnetic moment with decreasing temperature is indicative of zero-field splitting with D approximately 4 cm(-1).

Charge-transfer spectra of structurally characterized mixed-valence thiolate-bridged Cu(I)/Cu(II) cluster complexes.

A series of Cu(II) and Cu(I)/Cu(II) complexes containing the cis-N(amine)(2)S(thiolate)(2) copper complex rac-2 has been synthesized to provide a basis for understanding the charge-transfer spectra of mixed-valence thiolate-bridged Cu(I)/Cu(II) complexes. In combination with Cu(Me(2)-13-N(4)ane), rac-2 yields a monobridged dinuclear homovalent adduct, rac-5, while reaction with CuCl yields the mixed-valance pentanuclear complex rac-6. In the presence of Cu(II)(acac)(2), chiral R,R-1 reacts to form a mixed-valence pentanuclear cation R,R-7. rac-6 exhibits a relatively short Cu(I). Cu(II) contact [2.8231(9) A] and associated structural features that suggest the presence of a weak Cu(I).Cu(II) interaction in a valence-trapped system. Additional structural features in rac-6 and R,R-7 include singly and doubly bridging thiolates, three- and four-coordinated Cu(I) ions, and varying Cu(I) ligand sets. These features extend the types and complexities of electronic absorptions significantly. Spectra of rac-6 and R,R-7 exhibit multiple overlapping absorptions over the entire visible and ultraviolet spectral regions studied, consonant with these observations. Trends resulting from variations in structure type and oxidation state permit a first approach toward developing a detailed assignment of the individual ligand Rydberg, LF, LMCT, MLCT, and possible MMCT absorptions in these complexes.

A Tethered Porphyrin Dimer with π Overlap of a Single Pyrrole Ring.

The special pair of the bacterial photosystem has been modeled with a porphyrin dimer (the partial structure is shown). As with the natural system, only one pyrrole ring from each monomer subunit participates in π overlap.